Additional Documents
1 PDF: Correspondence from Minister for Veterans' Affairs, The Hon Darren Chester MP, response to Committee Chair, received 18 September 2018. Correspondence from Minister for Veterans' Affairs, The Hon Darren Chester MP, response to Committee Chair, received 18 September 2018.
2 PDF: Clarification of evidence provided on 8 November 2018 from Biocelect Pty Ltd, received 19 November 2018. Clarification of evidence provided on 8 November 2018 from Biocelect Pty Ltd, received 19 November 2018.
3 PDF: Additional information provided by Roche Products, received 19 November 2018. Additional information provided by Roche Products, received 19 November 2018.

See Also

Other information presented to the inquiry

Committee Secretariat contact:

Foreign Affairs, Defence and Trade Committee
Department of the Senate
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3535
Fax: +61 2 6277 5818
fadt.sen@aph.gov.au

About this inquiry

Inquiry into the use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force.



Past Public Hearings

08 Nov 2018: Canberra
05 Nov 2018: Melbourne
15 Oct 2018: Canberra

more...

Inquiry Status

Report Tabled

Accessibility

If you require any special arrangements to enable you to participate in the Committee's inquiry, please contact the Committee Secretariat.

Further information regarding accessibility can be found at www.aph.gov.au/Help/Accessibility